Telix Pharmaceuticals | TLX - Operating Profit

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD17.72M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Cochlear AUD 125.55M 149.05M Jun/2025
CSL USD 666M 1.31B Jun/2025
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Medical Developments International AUD -480K 662K Jun/2025
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Polynovo AUD 513K 902K Jun/2024
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
ResMed USD 500.3M 37.95M Dec/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024